← Back to Intel
Insider ActivityBCAX
Raben David, Chief Medical Officer at Bicara Therapeutics Inc., sold $104K of BCAX
Updated Jun 13, 2026
Raben David
Chief Medical Officer
Bicara Therapeutics Inc. ·
$BCAX
Transaction Details
| Insider | Raben David |
|---|---|
| Title | Chief Medical Officer |
| Company | Bicara Therapeutics Inc. |
| Ticker | BCAX |
| Transaction Type | Sale |
| Transaction Date | 2026-03-25 |
| Shares Traded | 5,500 |
| Price Per Share | $18.9508 |
| Total Value | $104K |
| Filed Date | 2026-03-26 |
| Accession Number | 0001628280-26-021543 |
Ownership Context
| Shares Owned After Transaction | 55,286 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001628280-26-021543
Other Insider Trades — BCAX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Simson Jake | Director | traded | — | 2026-06-09 |
| Haviland Kate | Director | traded | — | 2026-06-09 |
| RA CAPITAL MANAGEMENT, L.P. | Insider | traded | — | 2026-06-09 |
| Bowden Christopher | Director | traded | — | 2026-06-09 |
| POWELL MICHAEL | Director | traded | — | 2026-06-09 |
| Robertson Scott M. | Director | traded | — | 2026-06-09 |
| Mazumdar-Shaw Kiran | Director | traded | — | 2026-06-09 |
| Hyep Ivan | Chief Financial Officer | sold | $188K | 2026-05-21 |
| Hyep Ivan | Chief Financial Officer | traded | $35K | 2026-05-21 |
| Mazumdar Claire | Chief Executive Officer, Director | sold | $240K | 2026-05-18 |
Other Trades by Raben David
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | traded | $21K | 2026-04-27 |
| BCAX | Bicara Therapeutics Inc. | sold | $126K | 2026-04-27 |
| BCAX | Bicara Therapeutics Inc. | traded | $21K | 2026-03-25 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for BCAX — Bicara Therapeutics Inc. →
Track BCAX insider activity in real time on The Wire →
Get alerts when Raben David files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:20 UTC